Imbruvica 140 mg – DIN 02434407
Imbruvica is Ibrutinib 140 mg (capsule), sold in Canada. It is used for waldenstrom macroglobulinemia, b-cell chronic lymphocytic leukemia and b-cell lymphoma. It is supplied by Janssen Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Ibrutinib 140 mg
- Brand
- Imbruvica
- Strength
- 140 mg
- Used for
- Waldenstrom macroglobulinemia, b-cell chronic lymphocytic leukemia and b-cell lymphoma
- Form
- Capsule
- Manufacturer
- Janssen Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02434407
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Ibrutinib used for?
Ibrutinib is used for waldenstrom macroglobulinemia, b-cell chronic lymphocytic leukemia and b-cell lymphoma.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
IMBRUVICA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
. 2 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with 17p deletion
IMBRUVICA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) with 17p deletion.
. 3 Waldenström’s Macroglobulinemia
IMBRUVICA is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).
. 4 Chronic Graft versus Host Disease
IMBRUVICA is indicated for the treatment of adult and pediatric patients age 1 year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.
From the FDA-approved label on DailyMed (published Jan 08, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02434407.
- It names Imbruvica, Ibrutinib 140 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Imbruvica by Janssen Inc.
In Canada: prescription only.
Ingredients
Active: Ibrutinib
Other Ibrutinib pills
- ibr 140 mg Ibrutinib 140 mg White, capsule, 22 mm Used for waldenstrom macroglobulinemia and b-cell chronic lymphocytic leukemia
- ibr 140 Ibrutinib 140 mg Green, round, 9 mm Used for waldenstrom macroglobulinemia and b-cell chronic lymphocytic leukemia
- ibr 280 Ibrutinib 280 mg Purple, capsule, 15 mm Used for waldenstrom macroglobulinemia and b-cell chronic lymphocytic leukemia
- ibr 420 Ibrutinib 420 mg Green, capsule, 18 mm Used for waldenstrom macroglobulinemia and b-cell chronic lymphocytic leukemia
- ibr 70 mg Ibrutinib 70 mg Yellow, capsule, 18 mm Used for waldenstrom macroglobulinemia and b-cell chronic lymphocytic leukemia